Hepatocellular Carcinoma Clinical Trials in Phoenix, Arizona
5 recruitingPhoenix, Arizona
Showing 1–5 of 5 trials
Recruiting
Phase 1
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Solid Tumor+7 more
Exelixis1,314 enrolled122 locationsNCT05176483
Recruiting
Phase 1
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Metastatic Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Alnylam Pharmaceuticals158 enrolled23 locationsNCT06600321
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 1
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Hepatocellular CarcinomaAdvanced Solid Tumor
TORL Biotherapeutics, LLC70 enrolled10 locationsNCT06005740
Recruiting
Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
Virogin Biotech Canada Ltd97 enrolled3 locationsNCT05223816